These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12670751)

  • 1. Trandolapril and endothelin antagonist LU-135252 in the treatment of the fructose-induced hypertensive, hyperinsulinemic, hypertriglyceridemic rat.
    Ezra-Nimni O; Ezra D; Peleg E; Munter K; Rosenthal T
    Am J Hypertens; 2003 Apr; 16(4):324-8. PubMed ID: 12670751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat.
    Hofman C; Gabai E; Peleg E; Munter K; Rosenthal T
    Blood Press; 2005; 14(2):114-9. PubMed ID: 16036489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models.
    Orth SR; Odoni G; Karkoszka H; Ogata H; Viedt C; Amann K; Ferrari P; Ritz E
    Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
    Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.
    Adams J; Odoni G; Ogata H; Viedt C; Amann K; Ritz E; Orth SR
    Nephrol Dial Transplant; 2002 May; 17(5):780-7. PubMed ID: 11981063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
    Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M
    J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of allicin and enalapril in fructose-induced hyperinsulinemic hyperlipidemic hypertensive rats.
    Elkayam A; Mirelman D; Peleg E; Wilchek M; Miron T; Rabinkov A; Sadetzki S; Rosenthal T
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):377-81. PubMed ID: 11336185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin-converting enzyme inhibitors on fructose induced hypertension and hyperinsulinaemia in rats.
    Erlich Y; Rosenthal T
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S347-9. PubMed ID: 9072423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of blood pressure in normotensive dogs by endothelin.
    Münter K; Ehmke H; Kirchengast M
    Am J Physiol; 1999 Mar; 276(3):H1022-7. PubMed ID: 10070087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats.
    Kamari Y; Harari A; Shaish A; Peleg E; Sharabi Y; Harats D; Grossman E
    Hypertens Res; 2008 Jan; 31(1):135-40. PubMed ID: 18360028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat.
    Erlich Y; Rosenthal T
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):581-4. PubMed ID: 9554808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
    Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
    Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
    Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
    Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic T-type Ca2+ channel blockade with mibefradil in hyperinsulinemic, insulin-resistant and hypertensive rats.
    Verma S; Bhanot S; Hicke A; McNeill JH
    Cardiovasc Res; 1997 Apr; 34(1):121-8. PubMed ID: 9217881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
    Benigni A; Corna D; Maffi R; Benedetti G; Zoja C; Remuzzi G
    Kidney Int; 1998 Aug; 54(2):353-9. PubMed ID: 9690201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A; Amann K; Wagner J; Gehlen F; Münter K; Ritz E
    Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of nitric oxide to the beneficial effects of enalapril in the fructose-induced hyperinsulinemic rat.
    Erlich Y; Rosenthal T
    Hypertension; 1996 Nov; 28(5):754-7. PubMed ID: 8901819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminution of hypertriglyceridemia-induced pressor effect under hyperinsulinemic condition in normal and fructose-induced insulin resistant rats.
    Hsieh PS; Cheng WT; Liu TT; Loh CH; Chang BC
    Chin J Physiol; 2007 Jun; 50(3):99-104. PubMed ID: 17867429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.